Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity upon House Dust Mite Skin Challenge in Patients Suffering from Moderate to Severe Atopic Dermatitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2018
At a glance
- Drugs ANB 020 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacodynamics; Proof of concept
- Sponsors AnaptysBio
- 17 Feb 2018 Results published in the AnaptysBio media release.
- 17 Feb 2018 According to an AnaptysBio media release, data from this trial was presented at the American Academy of Dermatology (AAD) Annual Meeting (2018).
- 07 Feb 2018 Data from this trial will be presented at the 2017 American Academy of Dermatology (AAD) Annual Meeting, according to an AnaptysBio media release.